ProShares Ultra Health Care ETF

CRWV rebound, TSM earnings, PPI reaction

October 15, 2026

The tape rotated hard out of the AI complex into the rest of the market. The S&P 500 closed +0.33% at 7,744, the Dow jumped +1.08% to 52,178, the Nasdaq managed only +0.08% to 26,713, and the Russell 2000 rose ~1.3–1.4%. Breadth was solid (roughly 7 of 10 S&P names higher) after an early dip. The 10-year yield fell ~9–10 bp to ~5.08–5.10% even as September PPI printed hot at +1.3% m/m and +6.3% y/y (well above consensus). Stocks absorbed the inflation print via lower yields and a defensive/broad rotation; tech (especially chips and AI infrastructure) lagged after the prior session’s funding scare.

AI Infrastructure Funding Scare Meets Huang’s Pushback

The dominant catalyst remained the re-pricing of AI financing risk, centered on $Coreweave(CRWV.US). Bond yields on its notes spiked toward 15% earlier in the week, CDS widened sharply, and the stock dropped ~15% Wednesday amid Gartner commentary on neocloud longevity and broader worries about leveraged data-center build-outs. Elon Musk’s “yikes” reply to a bond-yield chart added to the noise.

Today $Coreweave(CRWV.US) rebounded ~6% (closing near $69.70) after Nvidia CEO Jensen Huang, speaking in Stockholm, said CoreWeave’s strength is “improving every day,” its cost of capital is decreasing, and he does not see a need for Nvidia to provide a bailout. Nvidia already holds ~10% of the company and has a multi-year capacity purchase commitment. The comments helped stabilize parts of the AI complex (some neocloud and related names pared losses), but credit-market stress had not fully disappeared and the broader semiconductor bid stayed selective. For swing traders, this is a classic sentiment-reset catalyst: the fundamental backlog ($100B+ contracted) and Huang’s endorsement matter more than the overnight bond panic, but elevated funding costs remain a live risk if utilization or pricing disappoints. Watch whether the rebound holds into the next earnings window and whether peers ($Oracle(ORCL.US), $Nebius(NBIS.US), etc.) follow.

$Taiwan Semiconductor(TSM.US) Crushes Numbers, Stock Still Soft

Taiwan Semiconductor reported another record quarter: profit up ~69% y/y, revenue well above guidance, and Q4 revenue outlook of $52.3–54.3B (strong sequential growth). Management reiterated extremely robust demand for leading-edge AI and HPC chips. The U.S.-listed shares still finished lower as the broader AI sell-off overshadowed the beat. The print reinforces the “picks-and-shovels” case for the foundry and its key customers ($NVIDIA(NVDA.US), $AMD(AMD.US), $Broadcom(AVGO.US)), but the market is currently more focused on the financing side of the build-out than on end-demand confirmation. Near-term, the reaction shows how quickly good fundamental news can be discounted when the narrative is about capital intensity and credit.

Other Catalysts and Earnings

$Ericsson(ERIC.US) rose after a solid Q3 beat: organic sales +7%, adjusted EBITA ahead of consensus, Networks strength and cost discipline. Management noted higher component costs will pressure margins next year, but the print was clean enough to drive a clear positive reaction.

Healthcare led sectors (XLV ~+1.8–2%), helped by rotation into defensives and specific catalysts such as $Moderna(MRNA.US) (+4–5% after a Goldman target raise tied to Phase 3 melanoma data optimism). $Eli Lilly(LLY.US), $Unitedhealth(UNH.US) and other large-caps participated.

Analyst activity included upgrades on names such as $Bank of America(BAC.US) (to Outperform) and $Crocs(CROX.US), plus various initiations/resumptions, but nothing that redefined the tape the way the AI credit story and $Taiwan Semiconductor(TSM.US) print did.

Energy lagged (~-1.5%) despite some oil firmness; real estate and rate-sensitive areas benefited from the yield decline.

Healthcare, materials, consumer discretionary and financials led; technology and energy lagged. Equal-weight participation was healthier than the Nasdaq close implies—classic rotation rather than a broad risk-off day.

Notable Movers

Gainers: $Coreweave(CRWV.US) (rebound on Huang), $Ericsson(ERIC.US) (earnings), healthcare names, some Brazil-linked or other idiosyncratic moves from prior sessions continuing in pockets.

Decliners: Select AI/chip and infrastructure names that remained under pressure from the funding narrative; certain industrial or rate-sensitive names that did not fully participate in the Dow strength.

What Matters Next

Whether the $Coreweave(CRWV.US) rebound and Huang’s comments stabilize the AI financing narrative or if bond/CDS stress re-emerges (key for $NVIDIA(NVDA.US) and the broader complex).

More earnings (banks and others still reporting) and whether estimate revisions follow the $Taiwan Semiconductor(TSM.US) beat or stay muted by capital-cost worries.

Bond-market behavior with the 10-year near 5.1% after the hot PPI; a sustained yield drop would support the rotation, while a re-test of recent highs would pressure rate-sensitive and leveraged names.

FinTwit narratives around “AI overbuild vs. real demand” remain live—watch for continued debate on utilization, power, and funding costs versus pure semiconductor strength.

NFA / DYOR. This is market commentary based on public information and is not investment advice.

$SPY looks good, no problem. But my concern is this.

7 stocks still = 34% of the S&P 500. Higher concentration than the 2000 tech peak (~24%).

I got June stats from my agent:

$2.3T erased from Mag 7

MAGS ETF: $700M outflows, worst month since launch

6 of 7 names in double digit drawdowns

YTD split:

S&P 493: +13.7%

Mag 7 basket: -6.6%

The other 493 stocks carried 96% of index returns.

Where money rotated:

LEADING: Healthcare (XLV), Financials (XLF), Industrials (XLI)

LAGGING: Technology (XLK), Energy (XLE)

S&P 493 earnings growing ~20% in Q2.

Mag 7 growth slowing.

This is why I keep emphasizing on $RSP gives a better picture than $SPY. Equal weights are a better read IMHO.